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The regulation of adenylate cyclase has been analyzed in normal rat thyroid cells as well as in the same cells transformed 
by the v-rus-k oncogene. In both cell types the adenylate cyclase complex consists of the two GTP-binding proteins, G, 
and G,, as demonstrated by the specific ADP-ribosylation induced by pcrtussis and cholera toxin, respectively. The re- 
sponse of adenylate cyclase of the transformed cells to forskohn, pertussis toxin and cholera toxin is attenuated with 
respect to the control cell line. The thyrotropic hormone (TSH), that acts on normal thyroid cells in culture as a growth 
factor by stimulating the adenylate cyclase activity, is not able to induce DNA synthesis nor does it stimulate adenylate 
cyclase in was-k transformed cells. 
was-k oncogene; Thyrotropin; cyclic AMP; (Thyroid cell) 
1. INTRODUCTION 
FRTL-5 is a clonal cell line of differentiated rat 
thyroid cells that continue to divide when grown in 
the presence of thyrotropic hormone (TSH) [l]. 
Upon withdrawal of this hormone, the cells stop 
dividing, but maintain their viability and become 
hypersensitive to TSH with respect to CAMP pro- 
duction [2,3]. Thus TSH acts on these cells as a po- 
tent stimulator of adenylate cyclase activity and 
CAMP mediated thyroid functions such as iodide 
transport [4], growth [3] and protein synthesis [5]. 
It has been shown that these epithelial cells can 
be transformed by the Kirsten sarcoma virus [6-81. 
The v-ras-k transformed rat thyroid cell lines used 
in this study (KiKi and KiMol cell lines), exhibit 
very high levels of KiMSV mRNA and p21 on- 
cogene product [9]. Known biochemical activities 
associated with ras p21 proteins include GTP 
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binding and GTPases activity [lo], in addition, 
studies by Hurley et al. [l l] have demonstrated se- 
quence similarity between mammalian G-proteins 
and ~21. These observations suggest hat the p21 
ras proteins may function as GTPases and that 
they might belong to a distinct group of GTP- 
binding proteins that regulated normal cellular 
functions. When infected by the Kirsten murine 
sarcoma virus, FRTL-5 cells become completely 
transformed. In particular, the transformed cells 
are independent of TSH for their growth [8]. It is 
possible that the transformation process interrupts 
the hormone-stimulated adenylate cyclase 
pathway. This lesion in the signaling pathway 
could occur at the level of the TSH receptor, of the 
G-protein or of the adenylate cyclase enzyme. 
Since one function of G-proteins is to regulate 
adenylate cyclase in several cell systems [121, in the 
present work a series of experiments has been 
undertaken to study the effects of the v-rus-k gene 
product on adenylate cyclase in the rat thyroid cell 
system. 
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2. MATERIALS AND METHODS 3. RESULTS 
The FRTL-5 cells are a strain of cloned normal rat thyroid 
cells, previously shown to maintain the functional characteris- 
tics of iodide uptake and thyroglobulin synthesis [11. The KiMol 
cells are FRTL-5 cells infected with the Kirsten sarcoma virus 
(KiMSV-MoMuLV). The KiKi cells are a different cell line of 
FRTL-5 cells independently infected with the Kirsten sarcoma 
virus (KiMSV-KiMuLV), with a transformed phenotype iden- 
tical to KiMol cells [6-81. 
DNA synthesis was evaluated by measuring the 
[‘Hlthymidine uptake as described [ 131. 
The intracellular CAMP content of FRTL-5, KiMol, and KiKi 
cells was measured by a method previously reported using a 
RIA technique (Biomedical Technologies, Inc., Cambridge, 
MA) [14], 0.5 mM IBMX was included in all assays. The 
amount of DNA in the different experiments was approx. 8 yg 
per well in the transformed cells and 14/17 pg in FRTL-5 cells. 
Adenylate cyclase activity in the cell homogenate was deter- 
mined according to the method of Solomon et al. [15]. 
Adenylate cyclase activity was calculated from quadruplicate 
samples and reported as the mean pmol of [a-‘*P]cAMP/mg of 
protein. Protein content was determined by the modified 
method of Lowry [16]. 
ADP-ribosylation activity was measured by following the in- 
corporation of [“P]ADP-ribose into membrane components, 
as described [14]. TSH used in ADP-ribosylation, CAMP, or 
other assays was a purified preparation [17]. Forskolin was ob- 
tained from Sigma; pertussis toxin from List Biological 
Laboratories, Campbell, CA; cholera toxin from Calbiochem- 
Behring, La Jolla, CA. 
Rat thyroid cells grown in the absence of TSH 
for two days, become quiescent and incorporate 
background levels of [3H]thymidine. Treatment 
with pure TSH allows the thyroid cells to enter the 
S phase [13]. It has been shown that TSH acts on 
FRTL-5 cells by inducing high levels of CAMP [3]. 
In order to verify whether forskolin (an adenylate 
cyclase stimulator [18]) was able to induce DNA 
synthesis in FRTL-5 cells, an [3H]thymidine incor- 
poration experiment was performed. Fig.1 shows 
that forskolin, at a concentration of 1 x lo-’ M, 
is able to stimulate DNA synthesis in the FRTL-5 
cells at levels similar to those induced by TSH. In 
contrast, in KiKi cells, neither TSH nor forskolin 
are able to induce DNA synthesis; only a slight ef- 
fect was observed with forskolin 1 x lo-’ M 
(fig.1). The KiKi cells are not quiescent, therefore 
their basal value is always higher than in the 
FRTL-5 cells. Yet one could expect an effect of 
forskolin and TSH since these cells can be 
stimulated, as is the case of 5% calf serum that in- 
duces a 5-fold increase in [3H]thymidine uptake 
(not shown). KiMol cells displayed a similar 
behavior (not shown). 
1x10-” 1 xlo-g 1x10-* TSt 
FORSKOLIN (tvl) 
Fig. 1. Incorporation of [‘Hlthymidine in (A) FRTL-5 (0) and KiKi (0) cells after TSH treatment. (B) FRTL-5 (0) and KiKi (0) cells 
after forskolin treatment. The stimulation fold indicates the ratio of incorporation into trichloroacetic acid-precipitable material for 
the stimulated culture relative to incorporation into unstimulated cells. 
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Table 1 
Levels of CAMP in KiKi, KiMol and FRTLS cells stimulated 
with various compounds 
KiKi KiMol FRTLS 
Control” 0.7 + 0.1 (5) 0.5 + 0.1 (5) 0.85 & 0.2 (4) 
Cholera toxin 
(lo-* M) 9.9 + 0.5 (3) 6.5 + 0.8 (3) 26 + 4 (3) 
Pertussis toxin 
(lo-’ M) 0.9 * 0.1 (3) 0.5 * 0.2 (3) 2 * 0.2 (3) 
Forskolin 
(lO-6 M) 7.6 + 0.7 (4) 7.3 + 0.4 (3) 12 + 1.7 (3) 
TSH (lO-6 M) 2 + 0.4 (5) 0.7 + 0.1 (4) 21 + 1 (3) 
a CAMP (pmol/well). The CAMP assay was performed as 
described [30]. The incubation with the various compounds 
was for 1 h at 37°C. In parentheses are the number of 
experiments, each performed in duplicate. The data are 
presented as mean + SE. FRTLS cells were maintained 
without TSH in the medium for 5 days prior to the CAMP 
determination 
To study the possible role that tas proteins could 
play in the regulation of the adenylate cyclase in v- 
ras transformed cells, we first examined the CAMP 
content in the presence and in the absence of TSH. 
The intracellular levels of CAMP were slightly af- 
fected in the two v-ras-k transformed cell lines, 
when compared to the pronounced effect observed 
in the FRTL-5 cells (see table 1). In fact a slight in- 
crease (about 2-fold) was present in the KiKi cell 
line stimulated by TSH, whereas no effect was 
detected in the KiMol cells. The basal intracellular 
CAMP content in FRTL-5 cells was similar to that 
found in the two transformed thyroid cell lines. 
Ki-Ki Ki-Mol 
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Fig.2. Autoradiographic analysis of ADP-ribosylated proteins 
in KiKi and KiMol cell membranes which were incubated with 
pertussis toxin (PT, 1 x IO-’ M) and cholera toxin (CT) in the 
assay mixture (see section 2). The molecular masses of the 
various bands are indicated. 
Table 1 shows that cholera toxin and forskolin 
increase CAMP levels in normal and in the two 
transformed cell lines. However, the extent of this 
increase is higher in the normal cell when com- 
pared to the transformed ones. Unlike the normal 
cells pertussis toxin does not increase the CAMP 
level in the two transformed cell lines (table 1). 
It has recently been shown that Gi and G, can be 
demonstrated in FRTL-5 cells by their specific 
1 x10-e 1 x10-5 1 x10-. 
FORSKOLIN CM) 
Fig.3. Adenylate cyclase activity in normal FRTL-5 (0) and transformed KiMol cells (e) after forskolin treatment. The data represent 
the mean of quadruplicate determination, in all cases the SD was <5% of the mean. 
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ADP-ribosylation produced by pertussis and 
cholera toxin, respectively [14]. We have perform- 
ed similar experiments in the transformed cell lines 
and shown that the peptide identifiable as ai 
(40 kDa) and ays (42 kDa and 45 kDa) observed in 
FRTL-5 cells are also present in the KiKi and 
KiMol cells (fig.2). 
It was found that the activity of adenylate 
cyclase varies with the rate or phase of cell growth 
[19]. We have therefore measured forskolin- 
stimulated adenylate cyclase activity in membranes 
isolated from normal and transformed cell lines 
grown exponentially. Fig.3 shows that forskolin 
stimulates the adenylate cyclase activity in normal, 
as well as in KiMol cell lines. The levels of stimula- 
tion are lower in the transformed cells. Ions such 
as magnesium and manganese which activate 
directly G-proteins, increase the CAMP level in 
normal and transformed cells (not shown). Mem- 
branes from normal and transformed cells were 
then studied for their ability to catalyze the forma- 
1x10' 1x10-' 1x10-e 1x10-5 1x10-' GPP(NH) P(M) 
Fig.4. Adenylate cyclase activity in normal FRTL-5 (0) and 
transformed KiMol cells (0) after GPP(NH)P treatment. The 
data represent he mean of quadruplicate determinations, in all 
cases the SD was ~5% of the mean. 
tion of CAMP in the presence of different concen- 
trations of the non-hydrolyzable analog of GTP, 
GPP(NH)P, which leads to a persistent ‘activated 
state’ of the enzyme. Fig.4 shows that the degree of 
adenylate cyclase stimulation is higher in normal 
cells with respect to the transformed ones. The 
GPP(NH)P stimulation of transformed rat thyroid 
cells in the presence of TSH (lo-’ M) remain un- 
changed (not shown), suggesting a lack of interac- 
tion between the TSH receptor and the G, protein. 
4. DISCUSSION 
It has been shown that TSH acts in FRTL-5 cells 
as a growth factor by inducing thymidine uptake 
and cell proliferation [5,13]. In the v-ras-k 
transformed cells TSH is neither able to induce cell 
proliferation nor thymidine uptake, and it is not 
able to stimulate the adenylate cyclase as 
demonstrated both in intact cells and in isolated 
membranes. A small effect of the hormone was 
demonstrated in the KiKi cell line (table 1) at a con- 
centration lOOO-fold higher than that effective in 
normal cells [3,14,20]. A possible alteration pre- 
sent at the TSH receptor level could be the cause 
of the insensitivity of these transformed cells to the 
hormone. Preliminary evidence, however, suggests 
that the TSH receptor is present in these v-ras-k 
transformed cells [21]. 
Forskolin and cholera toxin stimulate adenylate 
cyclase in the two transformed cell lines analyzed 
here; this stimulation however is smaller than that 
shown in normal cells. This is in agreement with 
previous studies on a different strain of rat thyroid 
cells [22] and on mammalian ras-transfected 
fibroblasts [23,24]. The decreased stimulation 
caused by cholera toxin (30-fold in control cells, 
1Cfold in the transformed ones) could be due 
either to a decreased amount of G5 present in the 
transformed cells and/or inactivated G, or to an 
attenuated adenylate cyclase. From data obtained 
in the ADP-ribosylation experiments there is no 
apparent difference in the amount of G, protein in 
normal and transformed cells. 
Pertussis toxin did not affect adenylate cyclase 
activity in the transformed cell lines. The effect of 
the toxin is indeed small also in normal thyroid 
cells (Zfold increase). If, as shown for the other 
stimulators, we assume a smaller effect of the toxin 
in the transformed cells than in the normal cells, it 
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would have been difficult to detect such an effect 
under our experimental conditions. Another 
possibility is that Gi is not inhibiting the adenylate 
cyclase complex in the transformed cells, therefore 
the effect of the toxin at the Gi level is not 
translated into an increase in CAMP. The proof of 
this hypothesis would require however the stimula- 
tion of inhibitory receptors coupled to Gi, which 
have not yet been identified in these cells. 
In summary, our results are consistent with 
previous studies suggesting a decreased stimulation 
of adenylate cyclase activity in cells transformed 
by a variety of viral oncogenes [23]. G-proteins are 
present in the two independently infected thyroid 
cells and the stimulation of cyclase by GTP 
analogs indicates a role of G-proteins in the regula- 
tion of the enzyme. Probably the differences in the 
response to the TSH hormone between v-ras-k 
transformed and normal cells may be due to an in- 
active receptor or to a lack of receptor-G-protein 
interaction. Forskolin which is able to increase 
CAMP levels also in transformed cells induces only 
a slight increase in the [3H]thymidine uptake. This 
suggests that CAMP per se is not sufficient to 
stimulate growth in the transformed cells and that 
probably endocrine factors, that activate different 
signals and pathways, may be important in this 
regulation. 
Acknowledgements: This work was supported by contract 
84.009.15.51, from the Consiglio NazionaIe delle Ricerche, 
Progetto Finalizzato CNR lngegneria Genetica e Basi 
Molecolari delle Malattie Ereditarie, by contract 87.00032.04 
from the Consiglio Nazionale delle Ricerche, and by FIDIA 





Ambesi-Impiombato, F.S., Parks, L.A.M. and Coons, 
H.G. (1980) Proc. Natl. Acad. Sci. USA 79, 6680-6685. 
Mandato, E., Catapano, R., Ambesi-Impiombato, F.S. 
and Macchia, V. (1981) Biochim. Biophys. Acta 676, 
91-100. 
[3] Valente, W.A., Vitti, P., Kohn, L., Brandi, M.L., 
Rotella, C., Toccafondi, R., Tramontano, D., Aloj, S.M. 
and Ambesi-Impiombato, F.S. (1983) Endocrinology 112, 
71-79. 
[4] Weiss, S.J., Philp, N.J., Ambesi-Impiombato, F.S. and 
Grollman, E.F. (1984) Endocrinology 144, 1099-l 107. 
[5] Khon, L.D., Aloj, S.M., Tombaccini, D., Rotella, C.M., 
Toccafondi, R., Marcocci, C., Corda, D. and Grollman, 
E.F. (1985) in: The Thyrotropin Receptor Biochemical 
Action of Hormones, vol.XII, chapt. 14, pp.457-511. 



















Vecchio, G. and Tsuchida, N. (1981) Int. J. Cancer 28, 
655-662. 
Fusco, A., Pinto, A., Tramontano, D., Tajana, G., 
Vecchio, G. and Tsuchida, N. (1982) Cancer Res. 42, 
618-626. 
Colletta, G., Pinto, A., Di Fiore, P.P., Fusco, A., 
Ferrentino, M., Avvedimento, V.E., Tsuchida, N. and 
Vecchio, G. (1983) Mol. Cell. Biol. 3, 2099-2109. 
Ferrentino, M., Di Fiore, P.P., Fusco, A., Colletta, G., 
Pinto, A. and Vecchio, G. (1984) J. Gen. Viral. 65, 
1955-1961. 
Scolnick, E.M., Papageorge, A.G. and Shih, T.Y. (1979) 
Proc. Natl. Acad. Sci. USA 76, 5355-5359. 
Hurley, J.B., Simon, M.I., Teplow, D.B., Robishaw, 
J.D. and Gilman, A.G. (1984) Science 226, 860-862. 
Gilman, A. (1984) Cell 36, 577-579. 
Colletta, G., Cirafici, A.M. and Vecchio, G. (1986) 
Science 233, 458-481. 
Corda, D., Sekura, R.D. and Kohn, L.D. (1987) Eur. J. 
Biochem. 166, 465-481. 
Solomon, Y., Londos, C. and Rodbell, M. (1974) Anal. 
Biochem. 58, 541-548. 
Markwell, M.A.K., Hass, S.M., Bieber, L.L. and 
Tolbert, N.E. (1974) Anal. Biochem. 87, 206-210. 
McKenzie, J.M. (1958) Endocrinology 63, 372-384. 
Seamon, K.B., Padgett, W. and Daly, J.W. (1981) Proc. 
Natl. Acad. Sci. USA 78, 3363-3367. 
Anderson, W.B., Russel, T.R., Carchman, R.A. and 
Pastan, I. (1973) Proc. Natl. Acad. Sci. USA 70, 
3502-3505. 
Corda, D. and Khon, L.D. (1985) Proc. Natl. Acad. Sci. 
USA 82, 8677-8680. 
Colletta, G., Pinto, A., Schettini, G., Cirafici, A.M., 
Marinaccio, M. and Consiglio, E. (1985) in: Cell 
Membranes and Cancer (Galeotti, T. et al. eds) 
pp. 101-106, Elsevier, Amsterdam, New York. 
Spina, A., Di Donato, A., Colella, G., Illiano, G., 
Berlingieri, M.T., Fusco, A. and Grieco, M. (1987) Bio- 
them. Biophys. Res. Commun. 142, 527-535. 
Tarplay, W.G., Hopkins, N.K. and Gorman, R.R. (1986) 
Proc. Natl. Acad. Sci. USA 83, 3703-3707. 
Levitzki, A., Ruddick, J., Pastan, I., Vass, W.C. and 
Lowy, D.R. (1986) FEBS Lett. 197, 134-138. 
41 
